MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation

被引:138
作者
Romano, Giulia [2 ,3 ]
Acunzo, Mario [3 ]
Garofalo, Michela [3 ]
Di Leva, Gianpiero [3 ]
Cascione, Luciano [3 ,4 ]
Zanca, Ciro [1 ]
Bolon, Brad [5 ]
Condorelli, Gerolama [1 ]
Croce, Carlo M. [3 ]
机构
[1] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Endocrinol & Oncol Sperimentale IEOS Consiglio Na, Fac Biotechnol Sci, I-80134 Naples, Italy
[2] Fdn Ist Ricovero & Cura Carattere Sci IRCCS Studi, I-80143 Naples, Italy
[3] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA
[4] Univ Catania, Dept Clin & Mol Biomed, I-95125 Catania, Italy
[5] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA
关键词
drug resistance; noncoding small RNA; CHRONIC LYMPHOCYTIC-LEUKEMIA; PROTEIN-KINASE-C; PEA-15; ASTROCYTES; MICRORNA-494; RESISTANCE; PATHWAY; PHOSPHORYLATION; PROLIFERATION; PED/PEA-15;
D O I
10.1073/pnas.1207917109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
MicroRNAs (miRNAs) have an important role in the development of chemosensitivity or chemoresistance in different types of cancer. Activation of the ERK1/2 pathway is a major determinant of diverse cellular processes and cancer development and is responsible for the transcription of several important miRNAs. Here we show a link between the ERK1/2 pathway and BIM expression through miR-494. We blocked ERK1/2 nuclear activity through the overexpression of an ERK1/2 natural interactor, the protein PED/PEA15, and we performed a microRNA expression profile. miR-494 was the most down-regulated microRNA after ERK1/2 inactivation. Moreover, we found that miR-494 induced Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) resistance in non-small-cell lung cancer (NSCLC) through the down-modulation of BIM. Elucidation of this undiscovered ERK1/2 pathway that regulates apoptosis and cell proliferation through miR-494 in NSCLC will greatly enhance our understanding of the mechanisms responsible for TRAIL resistance and will provide an additional arm for the development of anticancer therapies.
引用
收藏
页码:16570 / 16575
页数:6
相关论文
共 30 条
[1]   miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222 [J].
Acunzo, M. ;
Visone, R. ;
Romano, G. ;
Veronese, A. ;
Lovat, F. ;
Palmieri, D. ;
Bottoni, A. ;
Garofalo, M. ;
Gasparini, P. ;
Condorelli, G. ;
Chiariello, M. ;
Croce, C. M. .
ONCOGENE, 2012, 31 (05) :634-642
[2]   Bim-targeted cancer therapy: A link between drug action and underlying molecular changes [J].
Akiyama, Toru ;
Dass, Crispin R. ;
Choong, Peter F. M. .
MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12) :3173-3180
[3]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[4]  
ARAUJO H, 1993, J BIOL CHEM, V268, P5911
[5]   Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia [J].
Calin, GA ;
Dumitru, CD ;
Shimizu, M ;
Bichi, R ;
Zupo, S ;
Noch, E ;
Aldler, H ;
Rattan, S ;
Keating, M ;
Rai, K ;
Rassenti, L ;
Kipps, T ;
Negrini, M ;
Bullrich, F ;
Croce, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (24) :15524-15529
[6]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[7]   PED/PEA-15:: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis [J].
Condorelli, G ;
Vigliotta, G ;
Cafieri, A ;
Trencia, A ;
Andalò, P ;
Oriente, F ;
Miele, C ;
Caruso, M ;
Formisano, P ;
Beguinot, F .
ONCOGENE, 1999, 18 (31) :4409-4415
[8]   The MAPK signalling pathways and colorectal cancer [J].
Fang, JY ;
Richardson, BC .
LANCET ONCOLOGY, 2005, 6 (05) :322-327
[9]   PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase [J].
Formstecher, E ;
Ramos, JW ;
Fauquet, M ;
Calderwood, DA ;
Hsieh, JC ;
Canton, B ;
Nguyen, XT ;
Barnier, JV ;
Camonis, J ;
Ginsberg, MH ;
Chneiweiss, H .
DEVELOPMENTAL CELL, 2001, 1 (02) :239-250
[10]   The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure [J].
Freson, K ;
De Vos, R ;
Wittevrongel, C ;
Thys, C ;
Defoor, J ;
Vanhees, L ;
Vermylen, J ;
Peerlinck, K ;
Van Geet, C .
BLOOD, 2005, 106 (07) :2356-2362